Bioequivalence study 2 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers
3135003
Phase 1 other active
Quick answer
Bioequivalence study 2 to compare pharmacokinetics of Parkinson´s disease drugs in healthy volunteers for Parkinson desease is a Phase 1 program (other) at Orion with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Orion
- Indication
- Parkinson desease
- Phase
- Phase 1
- Modality
- other
- Status
- active